Cargando…

528. Hospital Course of Patients Receiving Bamalanivimab: A Real World Analysis

BACKGROUND: Monoclonal antibodies for the outpatient treatment of the novel Coronavirus Disease 2019 (COVID-19) first received emergency use authorization from the Food and Drug Administration in November 2020. These antibodies have been associated with a reduction in emergency department visits and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belk, Madeline, Edwards, Jonathan, Hassoun, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644372/ http://dx.doi.org/10.1093/ofid/ofab466.727

Ejemplares similares

528. Coronavirus Disease 2019 in Children Cared for at Texas Children’s Hospital: Implications of Repeat Testing on Infection Control Strategies
por: Foster, Catherine, et al.
Publicado: (2020)

70. Impact of the Accelerate Pheno™ System on Clinical and Antimicrobial Outcomes among Inpatients with Gram-Negative Bacteremia at a 528-bed Community Teaching Hospital
por: DePasquale, William P, et al.
Publicado: (2021)

Evaluation of telavancin dose capping in a large community hospital
por: Hassoun, Ali, et al.
Publicado: (2017)

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
por: Oglesby, Alan, et al.
Publicado: (2021)

Multidisciplinary Approach to Improve Utilization and Cost Savings of Multiplex Polymerase chain reaction (PCR) Respiratory Pathogen Testing in a Large Community Hospital
por: Hassoun, Ali, et al.
Publicado: (2017)

Utilization of the T2 Candida Panel for Rapid Candida Species Detection in a Large Community Hospital
por: Hassoun, Ali, et al.
Publicado: (2017)

Clinical and Economic Evaluation of commercialized Fecal Microbiota Transplant (cFMT) for Patients with Recurrent Clostridium difficile Infection (CDI) in a Large Community Hospital
por: Hassoun, Ali, et al.
Publicado: (2017)

1119. Impact of Real-World and Real-Time Interdisciplinary Cases on Infectious Diseases Content Knowledge and Confidence in Pharmacy Students Enrolled in an Infectious Diseases Elective Course
por: Rybakov, Ilya, et al.
Publicado: (2020)

1577. Real-World, Multicenter Experience with Eravacycline for Various Infections
por: Alosaimy, Sara, et al.
Publicado: (2020)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

PM528. The key factor in reducing prevalence of cardiovascular disease and metabolic syndrome among Japanese chronic schizophrenia
por: Nakamura, Dan, et al.
Publicado: (2016)

528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients
por: Haddad, Andrea, et al.
Publicado: (2023)

572. Real-world Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in a Retrospective Cohort
por: Vahidy, Farhaan S, et al.
Publicado: (2021)

762. Real-World Utilization of C. difficile Drug Treatments and Associated Clinical Outcomes in a US Hospital System
por: McDaniel, Lauren, et al.
Publicado: (2021)

1034. FebriDx use in Immunocompromised Patients in a Real-World Hospital Setting during the second (COVID-19) wave in Italy
por: Lagi, Filippo, et al.
Publicado: (2021)

528 Elevated Asthma Prevalence in Mexican-American Children in El Paso, Texas
por: Ruiz-Payan, Alma
Publicado: (2012)

Trio sonatas, BWV 528, 529 and 530
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1993)

P528: CAN MULTIPARAMETRIC FLOW CYTOMETRY OF PERIPHERAL BLOOD CHALLENGE BONE MARROW ANALYSES FOR DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA?
por: Schadt, Jonas, et al.
Publicado: (2023)

1627. Tedizolid is Well-tolerated Among Patients Receiving Prolonged Treatment Courses, Including Those Who are Intolerant of Alternative Agents
por: Smith, Brandon, et al.
Publicado: (2020)

811. Utilizing IV team in Reducing the Central Line Associated Infections
por: Srialluri, Swetha, et al.
Publicado: (2020)

528 Evaluation of phosphate replacement practices in burn patients
por: Derisse, Giae Surine S, et al.
Publicado: (2022)

1383. Characterizing Real-world Patterns of Early Childhood Vaccination
por: Butler, Anne M, et al.
Publicado: (2020)

256. Optimizing the Clinical Utilization of T2 Rapid Candida Panel at a Large Community Hospital
por: Thottacherry, Elizabeth, et al.
Publicado: (2019)

P1747: A REAL-WORLD ANALYSIS OF HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED TREATMENT WITH RAVULIZUMAB
por: Fishman, J., et al.
Publicado: (2022)

746. Comparing Hospital Course in Hospitalized Patients Infected with Babesiosis Versus Patients Coinfected with Lyme Disease and Babesiosis
por: Spector, Rachel, et al.
Publicado: (2020)

729. Real World Efficacy of Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Immunosuppressed Patients
por: Perreault, Sarah, et al.
Publicado: (2020)

210. Vancomycin Infusion Frequency and Intensity: Analysis of Real-World Data Generated from Automated Infusion Devices
por: Yamaga, Cynthia, et al.
Publicado: (2020)

590. Vancomycin Infusion: Algorithmic Analysis of Unstructured Real-World Data Captured from Automated Infusion Devices
por: Bostick, David L, et al.
Publicado: (2020)

528. Longitudinal Evaluation of Chlorhexidine Resistance Among Multidrug-Resistant Organisms in Relation to Intervention of Daily Chlorhexidine Bathing in Adult Intensive Care Units
por: Ja Kim, Min, et al.
Publicado: (2019)

400. Secondary Infections in COVID-19 Patients Receiving Tocilizumab in a Community Hospital
por: Usiak, Shauna, et al.
Publicado: (2020)

829. Identification of Congenital Cytomegalovirus Infection Using Real-World Healthcare Data
por: Weil, Clara, et al.
Publicado: (2020)

1270. Early Real-world Evidence in the Use of Eravacycline for the Management of Draconian Infections
por: Carr, Amy, et al.
Publicado: (2020)

1247. Dalbavancin in Osteomyelitis and Joint Infections: An Analysis From an Observational, Multicenter, Retrospective Cohort Study of the Real-World Use in Adult Patients
por: Diaz, Julia Garcia, et al.
Publicado: (2020)

281. Prevalence of Influenza Co-infection in a Real-world Cohort of COVID-19 Patients in the U.S
por: Chawla, Devika, et al.
Publicado: (2021)

571. “Real world” Impact of Letermovir for Prevention of Cytomegalovirus Infection in Hematopoietic-Cell Transplantation
por: Loecher, Alyssa M, et al.
Publicado: (2020)

279. Dalbavancin for Bloodstream Infections and Endocarditis: Real-World Outcomes From the DRIVE Registry
por: Gonzalez, Pedro, et al.
Publicado: (2020)

1082. Real-World Experience with Omadacycline for Nontuberculous Mycobacterial Infections: A Multicenter Evaluation
por: Morrisette, Taylor, et al.
Publicado: (2021)

807. Effect of Inter-Hospital Transfer on Nosocomial Infection Rates in Patients Receiving Extracorporeal Membrane Oxygenation
por: Marcus, Joseph E, et al.
Publicado: (2020)

1311. Intrapulmonary Pharmacokinetics of Cefiderocol in Hospitalized and Ventilated Patients Receiving Standard of Care Antibiotics for Bacterial Pneumonia
por: Katsube, Takayuki, et al.
Publicado: (2020)

1625. Real-World Outpatient Utilization of Ceftolozane/Tazobactam in Physician Office Infusion Centers (OICs)
por: Van Anglen, Lucinda J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ho0uismmc4961ifp3rfte5j74g